Summary
It has been reported previously that antisera produced in non human primates against many cultured human melanoma lines recognize tumorassociated antigens on the melanoma cells. The reactivity correlated with other parameters of malignancy, such as rapidity of tumor growth in nude mice and release of plasminogen activator. In this study we have investigated whether these antisera also react with non melanoma cancer lines and searched for a correlation between this reaction and the other parameters of malignancy. There was cross-reactivity of the ten sera with 4–43% of the 46 non melanoma lines compared to 62–100% of the 16 melanoma lines, indicating a preferential reactivity with melanoma lines. For the non melanoma lines no correlation was found between the release of plasminogen activator, the degree of tumorigenicity in the nude mouse or the reactivity of surface antigens as detected with antimelanoma sera.
Similar content being viewed by others
References
Attia NA, Weiss DW (1966) Immunology of spontaneous mammary carcinoma in mice. V. Acquired tumor resistance and enhancement in strain A mice infected with mammary tumor virus. Cancer Res 26:1787–1800
Bosmann H, Bieber GF, Brown AE, Case KR, Gersten D (1974) Biochemical parameters correlated with tumor cell implantation. Nature 246:487–489
Brüggen J, Sorg C, Macher E (1978) Membrane-associated antigens of human malignant melanoma. V. Serological typing of cell lines using antisera from non-human primates. Cancer Immunol Immunother 5:53–62
Brüggen J, Helming W, Macher E, Sorg C (1979) Biochemical and serological characterization of cell surface structures and their correlation to the state of malignancy in human malignant melanoma. Immunobiology 156:256 (Abstract)
Brüggen J, Macher E, Sorg C (1981) Expression of surface antigens and its relation to parameters of malignancy in human malignant melanoma. Cancer Immunol Immunother 10:121–127
Christman JK, Acs G, Silagi S, Silverstein SC (1975) Plasminogen activator: biochemical characterization and correlation with tumorigenicity. In: Reich E, Rifkin DB, Shaw E, (eds) Proteases and biological control. Cold Spring Habor, New York (Cold Spring Habor Laboratory), pp 827–839
Fogh J, Fogh H (1969) Procedures for control of mycoplasma contamination of tissue cultures. Ann NY Acad Sci 172:15–30
Fogh J, Fogh JN, Orfeo T (1977) One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst 59:221–225
Fogh J, Bean MA, Brüggen J, Fogh H, Fogh JN, Hammar SP, Kodera Y, Loveless JD, Sorg C, Wright WC (1978) Comparison of a human tumor cell line before and after growth in the nude mouse. In: Fogh J, Giovanella BC (eds) The nude mouse in experimental and clinical research. Academic Press, New York, pp 215–235
Gidlund M, Örn A, Wigzell H, Senik A, Gresser I (1978) Enhanced NK cell activity in mice injected with interferon and interferon inducers. Nature 273:759–761
Giovanella BC, Stehlin JS, Williams LJ (1972) Development of invasive tumors in the nude mouse after injection of cultured human melanoma cells. J Natl Cancer Inst 48:1531–1553
Giovanella BC, Stehlin JS, Williams LJ, Lee SS, Shepard RC (1978) Heterotransplantation of human cancers into nude mice. A model system for human cancer chemotherapy. Cancer 42:2269–2281
Giovanella BC, Fogh J (1978) Present and future trends in investiations with the nude mouse as a recipient of human tumor transplants. In: Fogh J, Giovanella BC (eds) The nude mouse in experimental and clinical research. Academic Press, New York, pp 281–313
Goldberg A (1974) Increased protease levels in transformed cells: a casein overlay assay for the detection of plasminogen activator production. Cell 2:95–102
Hajdu SI, Fogh J (1978) The nude mouse as a diagnostic tool in human tumor cell research. In: Fogh J, Giovanella BC (eds) The nude mouse in experimental and clinical research. Academic Press, New York, pp 235–267
Herbermann RB (1978) Natural cell-mediated cytotoxicity in nude mouse. In: Fogh J, Giovanella BC (eds) The nude mouse in experimental and clinical research. Academic Press, New York, pp 135–167
Jones PA, Laug WE, Benedict WF (1975) Fibrinolytic activity in a human fibrosarcoma cell line and evidence for the induction of plasminogen activator secretion during tumor formation. Cell 6:245–252
Killion JJ, Kollmorgen GM (1976) Isolation of immunogenic tumor cells by affinity chromatography. Nature 259:674–676
Klimetzek V, Sorg C (1977) Lymphokine-induced secretion of plasminogen activator by murine macrophages. Eur J Immunol 7:185–187
Klimetzek V, Sorg C (1979) The production of fibrinolysis inhibitors as a parameter of the activation state in murine macrophages. Eur J Immunol 9:613–619
Laug WE, Jones PA, Benedict WF (1975) Relationship between fibrinolysis of cultured cells and malignancy. J Natl Cancer Inst 54:173–179
Mak TW, Rutledge G, Sutherland DJA (1976) Androgen-dependent fibrinolytic activity in a murine mammary carcinoma (Shionogi SC 115 cells) in vitro. Cell 7:223–230
Montesano R, Drevon C, Kuroki T, Saint Vincent L, Handleman S, Sanford KK, DeFeo D, Weinstein IB (1977) Test for malignant transformation of rat liver cells in culture: cytology, growth in soft agar, and production of plasminogen activator. J Natl Cancer Inst 59:1651–1658
Mott DN, Fabisch PH, Sani BP, Sorof S (1974) Lack of correlation between fibrinolysis and the transformed state of cultured mammalian cells. Biochem Biophys Res Commun 61:621–626
Müller C, Sorg C (1975) Use of formalin fixed melanoma cells for the detection of antibodies against surface antigens by a micro-immune adherence technique. Eur J Immunol 5:175–178
Nagy B, Ban J, Brdar B (1977) Fibrinolysis associated with human neoplasia. Production of plasminogen activator by human tumors. Int J Cancer 19:614–620
Newcomb EW, Silverstein SC, Silagi S (1978) Malignant mouse melanoma cells do not form tumors when mixed with cells of a non-malignant subclone; relations between plasminogen activator expression by the tumor cells and the host's immune response. J Cell Physiol 95:169–178
Nicolson GL, Winkelhake JL (1975) Organ specificity of blood born tumor metastasis determined by cell adhesion? Nature 255:230–232
Nicolson GL, Birdwell CR, Brunson KW, Robbins JC, Beattie L, Fidler IJ (1977) Cell interactions in the metastatic process: some cell surface properties associated with successful blood born tumor spread. In: Lash JW, Burger MM (eds) Cell and tissue interactions. Raven Press, New York, pp 225–241
Nishioka K, Irie RF, Kawana T, Takeuchi S (1969) Immunological studies on mouse mammary tumors. III. Surface antigens reacting with tumor specific antibodies in immune haemolysis and immune adherence. Int J Cancer 4:139–149
Ossowski L, Reich E (1980) Loss of malignancy occurs during serial passage of human carcinoma in culture and discordance between malignancy and transformation parameters. Cancer Res 40:2310–2315
Poste G, Fidler IJ (1980) The pathogenesis of cancer metastasis. Nature 283:139–146
Reich E (1975) Plasminogen activator: secretion by neoplastic cells and macrophages. In: Reich E, Rifkin DB, Shaw E (eds) Proteases and biological control. Cold Spring Habor, New York (Cold Spring Harbor Laboratory), pp 333–341
San RHC, Rice JM, Williams GN (1977) Lack of correlation between plasminogen activating factor production and tumorigenicity in rat liver epithelial cells. Cancer Lett 3:242–245
Schirrmacher V, Shantz G, Clauer K, Komitowski D, Zimmermann H-P, Lohmann-Matthes M-L (1979) Tumor metastases and cell mediated immunity in a model system in DBA/2 mice. I. Tumor invasiveness in vitro and metastasis formation in vivo. Int J Cancer 23:233–244
Schirrmacher V, Bosslet K, Shantz G, Clauer K, Hübsch D (1979) Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. IV. Antigenic differences between a metastasizing variant and the parental tumor line revealed by cytotoxic T-lymphocytes. Int J Cancer 23:245–252
Seibert E, Sorg C, Happle R, Macher E (1977) Membrane-associated antigens of human malignant melanoma. III. Specificity of human sera reacting with cultured melanoma cells. Int J Cancer 19:172–178 Sharkey EF, Fogh JM, Hajdu SI, Fitzgerald PJ, Fogh J (1978) Experience in surgical pathology with human tumor growth in the nude mouse. In: Fogh J, Giovanella BC (eds) The nude mouse in experimental and clinical research. Academic Press, New York, pp 187–215
Silagi S (1976) Effects of 5-bromodeoxyuridine on tumorigenicity, immunogenicity, virus production, plasminogen activator, and melanogenesis of mouse melanoma cells. Int Rev Cytol 45:65–111
Unkeless JC, Gordon S, Reich E (1974) Secretion of plasminogen activator by stimulated macrophages. J Exp Med 139:834–850
Varani J, Orr W, Ward PA (1979) Cell-associated proteases affect tumor cell migration in vitro. J Cell Sci 36:242–251
Wilson EL, Dowdle E (1978) Secretion of plasminogen activator by normal reactive and neoplastic human tissues cultured in vitro. Int J Cancer 22:390–399
Wilson EL, Reich E (1979) Modulation of plasminogen activator synthesis and chick embryo fibroblasts by cyclic nucleotides and phorbol myristate acetate. Cancer Res 39:1579–1585
Yogeeswaran G, Stein BS, Sebastian H (1978) Altered cell surface organisation of gangliosides and sialylglycoproteins of mouse metastatic melanoma variant lines selected in vivo for enhanced lung implantation. Cancer Res 38:1336–1344
Yogeeswaran G, Sebastian H, Stein BS (1979) Cell surface sialylation of glycoproteins and glycosphingolipids in cultured metastatic variant RNA-virus transformed non-producer Balb/c 3T3 cell lines. Int J Cancer 24:193–202
Author information
Authors and Affiliations
Additional information
This is publication no. 7 of a series entitled “Membrane Associated antigens in Human Malignant Melanoma”
Supported by the Deutsche Forschungsgemeinschaft
Supported in part by Public Health Service (PHS) contract N01-CB43854 from the Division of Cancer Biology and Diagnosis, National Cancer Institute
Rights and permissions
About this article
Cite this article
Brüggen, J., Fogh, J. & Sorg, C. Tumor production in the nude mouse, fibrinolytic activity and cross-reactivity with antimelanoma sera of various human tumor cell lines. J Cancer Res Clin Oncol 102, 141–152 (1981). https://doi.org/10.1007/BF00410665
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00410665